Active Biotech AB Interim Report, January - September 2009
More News related to ACTI
- ActivIdentity Joins TSCP
- ActivIdentity (ACTI) Posts Q4 Loss of 1c, In-Line with Street
- ActivIdentity Reports Fourth Quarter Fiscal 2009 Financial Results
- Trading Radar for 11/19: Gap (GPS), Suntech Power (STP), Foot Locker (FL), Intuit (INTU), GameStop (GME) Report
- ActivIdentity Announces Fourth Quarter 2009 Earnings Release and Conference Call
More News related to Press Releases
- RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE)
- Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriag
- Largest Floating Christmas Tree in the World Inaugurated in Brazil
- AsiaInfo and Linkage to Merge
- Nihon Kohden America Announces the Auction of Its Latest EEG Technology in Support of the AES Lennox and Lombroso Trust for Epilepsy Research and Training
LUND, SWEDEN -- (MARKET WIRE) -- 11/05/09 --
* Laquinimod -- new data presented at ECTRIMS * 57-57 -- exploratory clinical trial in progress * RhuDex(TM) -- clinical development to continue following feedback from UK MHRA * ANYARA -- complete Phase I data published * TASQ -- complete Phase I data published * ISI -- project proceeding according to plan * Net sales of SEK 7.7 M (8.8) * Operating loss of SEK 164.6 M (loss: 167.0) * Loss after tax of SEK 165.1 M (loss: 162.0) * Loss per share for the period amounted to SEK 2.90 (loss: 3.30) * Number of shares at the end of the period, thousands (incl. warrants): 64,943 For further information, please contact: Tomas Leanderson President and CEO Tel: +46 (0)46-19 20 95 Göran Forsberg VP Investor Relations & Business Development Tel: +46 (0)46-19 11 54 Hans Kolam CFO Tel: +46 (0)46-19 20 44 Active Biotech AB (Corp. Reg. No. 556223-9227) PO Box 724, SE-220 07 Lund Sweden Tel: +46 (0)46-19 20 00 Fax: +46 (0)46-19 11 00 This report is also available at www.activebiotech.com
Active Biotech AB Interim Report, January - September 2009: http://hugin.info/1002/R/1352670/327332.pdf
This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
Copyright © Hugin AS 2009. All rights reserved.
Related Categories
Press ReleasesStocks Mentioned
+0.05Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
